Find Clinical Trial

Home » Find Clinical Trials » Evaluation of the pharmacodynamics, pharmacokinetics and safety of repeated escalating oral doses of S 38844 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction. A phase II, randomised, double-blind, parallel-group, placebo controlled, international multicentre study

Evaluation of the pharmacodynamics, pharmacokinetics and safety of repeated escalating oral doses of S 38844 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction. A phase II, randomised, double-blind, parallel-group, placebo controlled, international multicentre study

← Back

Study Phase	Phase 2

Therapeutic Area	Cardiovascular Diseases

Indication	Heart failure

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	S038844

Active Substance Code	S038844

Protocol Code	CL2-38844-010

EudraCT Code	2013-003000-39

Documents and links

Results summary	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.